Keloidiform Scar – Comprehensive Medical Guide
Overview
A keloidiform scar (commonly called a keloid) is an over‑growth of dense fibrous tissue that extends beyond the original boundaries of a skin injury. Unlike a typical (flat) scar, a keloid is raised, firm, and often pink, red, or hyperpigmented. It can continue to enlarge for months or years, even after the wound has fully healed.
Keloids are benign (non‑cancerous) but can cause pain, itching, and significant cosmetic concern. They most frequently appear on the chest, shoulders, upper back, earlobes, and cheeks—areas with high tension or abundant fibroblasts.
Who is affected? Keloids can develop in anyone who experiences a skin injury, but several groups are at higher risk:
- Individuals of African, Asian, or Hispanic descent (up to 15 % prevalence in these populations vs. < 1 % in Caucasians) 1.
- People with a family history of keloids—inheritance is believed to follow an autosomal dominant pattern with variable penetrance 2.
- Young adults aged 10–30 years, when skin is most active in collagen production.
- Patients with certain genetic disorders (e.g., Rubinstein‑Taybi syndrome, Goeminne‑Stewart syndrome).
Overall, keloids affect an estimated 6–16 % of the world’s population, though exact numbers vary by ethnicity and geographic region 3.
Symptoms
Keloids present a recognizable pattern of signs and sensations. The following list includes the most common manifestations:
- Raised, firm nodule – smooth or lobulated, often extending 2–5 mm (or more) above skin level.
- Color changes – may be pink, red, purple, or hyperpigmented compared with surrounding skin.
- Itching (pruritus) – reported by up to 70 % of patients; can be severe enough to disturb sleep.
- Pain or tenderness – especially when the scar is stretched or pressed.
- Burning or tingling sensation – secondary to nerve irritation.
- Restricted movement – when keloids form over joints or on the chest, they can limit range of motion.
- Progressive growth – unlike hypertrophic scars, keloids continue to expand beyond the original wound margin.
- Recurrence after removal – many patients experience regrowth after surgical excision if adjunct therapy is not used.
Causes and Risk Factors
Pathophysiology
Keloids result from a dysregulated wound‑healing cascade. Normally, fibroblasts lay down collagen (type III) in a controlled manner, which is later remodeled to type I collagen. In keloid formation, there is:
- Prolonged activity of fibroblasts and myofibroblasts.
- Excessive production of transforming growth factor‑beta (TGF‑β) and other profibrotic cytokines.
- Reduced collagen degradation due to low matrix metalloproteinase (MMP) activity.
The net effect is a surplus of collagen that grows outward, producing the characteristic bulky scar.
Risk Factors
- Genetic predisposition: Family history increases risk dramatically (up to 30 % of first‑degree relatives) 2.
- Skin pigmentation: Darker skin types (Fitzpatrick IV–VI) have higher fibroblast activity.
- Age: Adolescents and young adults heal faster, which correlates with higher incidence.
- Location of injury: High‑tension areas (chest, shoulders, earlobes) are more prone.
- Injury type: Surgery, piercings, burns, acne, scratches, or even vaccine injections can trigger keloids.
- Hormonal influences: Some reports suggest a link with estrogen, explaining a slight female predominance.
Diagnosis
Diagnosis is primarily clinical, based on history and visual examination. However, certain tools help confirm the diagnosis and rule out other lesions.
Clinical Evaluation
- History: Onset after trauma, progression pattern, family history, prior scar treatments.
- Physical exam: Assessment of size, morphology, color, and tenderness. A key feature is “extension beyond the original wound margins.”
Adjunct Tests (when needed)
- Dermatoscopy: Helps differentiate keloids from hypertrophic scars or dermatologic tumors.
- Ultrasound (high‑frequency): Measures scar thickness and vascularity; useful for planning treatment.
- Biopsy: Rarely required, but may be performed if malignancy (e.g., dermatofibrosarcoma protuberans) is suspected.
- MRI: Reserved for large, deep keloids causing functional impairment.
Treatment Options
Keloids are notorious for recurrence, so most experts recommend a multimodal approach—combining pharmacologic, procedural, and supportive measures.
First‑Line Non‑Invasive Therapies
- Silicone gel sheeting or sheets: Applied 12–24 hours/day for 3–6 months; reduces collagen production via occlusion. Success rates 40–60 % 4.
- Pressure therapy: Custom garments delivering 24 mmHg pressure, often used after ear piercing or surgical excision.
- Topical corticosteroids: Triamcinolone acetonide 0.1 % cream applied twice daily can soften early keloids.
Injectable Treatments
- Intralesional corticosteroids: Triamcinolone acetonide (10–40 mg/mL) injected every 4–6 weeks. Works by reducing fibroblast proliferation and inflammation. Response in 50–70 % of cases 5.
- 5‑Fluorouracil (5‑FU): Antimetabolite injected alone or with steroids; improves flattening, especially for resistant scars.
- Verapamil: Calcium‑channel blocker injected weekly; promotes collagen remodeling.
- Botulinum toxin type A: Reduces tension in nearby muscles, indirectly limiting keloid growth; emerging evidence suggests benefit as adjunct.
Procedural Options
- Surgical excision: Removes bulk of scar but carries >50 % recurrence if used alone. Must be combined with postoperative radiation, silicone, or steroids.
- Radiation therapy: Low‑dose (5–10 Gy) external beam or brachytherapy within 24 hours of excision; reduces recurrence to <10 % in selected studies 6.
- Laser therapy: Pulsed‑dye laser (PDL) targets vascularity, reducing redness and height; often paired with steroids.
- Cryotherapy: Freezes scar tissue; useful for small keloids.
- Radiofrequency & microneedling: Induce controlled injury to remodel collagen; modest efficacy.
- Photodynamic therapy (PDT): Investigational; uses light‑activated agents to inhibit fibroblast activity.
Systemic & Emerging Treatments
- Immunomodulators: Interferon‑α injections have shown limited benefit.
- Tranilast: Oral anti‑fibrotic agent approved in Japan; inhibits TGF‑β; off‑label use in the U.S. under investigation.
- Scar‑specific biologics: Agents targeting TGF‑β signaling (e.g., fresolimumab) are in early clinical trials.
Choosing a Treatment Plan
Management should be individualized. Small, early keloids often respond to silicone and steroids, whereas large, recurrent lesions may require excision plus radiation. Consultation with a dermatologist, plastic surgeon, or scar specialist is essential.
Living with Keloidiform Scar
Even after successful treatment, keloids can impact daily life. Below are practical strategies to minimise discomfort and maintain skin health.
Skin Care Routine
- Clean gently with non‑fragranced, pH‑balanced cleansers.
- Apply moisturiser containing hyaluronic acid or ceramides to keep tissue pliable.
- Use sunscreen (SPF 30+) on keloid‑prone areas; UV exposure can darken scars.
Symptom Management
- For itching, antihistamines (e.g., cetirizine) or topical pramoxine may provide relief.
- Apply cool compresses (10‑15 minutes) to calm inflammation.
- Gentle massage (2–3 minutes, 2–3 times daily) with a silicone‑based cream can improve flexibility.
Activity & Lifestyle
- Avoid tight clothing or jewelry that puts constant pressure on the scar.
- When exercising, warm‑up joints gradually to prevent stretching the scar.
- Maintain a healthy weight; excess adipose tissue can increase skin tension.
Psychological Support
Visible keloids can affect self‑esteem. Consider counseling, support groups, or cognitive‑behavioral therapy if you experience anxiety or depression related to your scar.
Prevention
While not all keloids are avoidable, risk can be lowered with proactive measures.
- Optimize wound care: Keep cuts clean, apply antibiotic ointment, and cover with a non‑adhesive dressing.
- Early silicone therapy: Start silicone gel sheets within weeks of wound closure, especially for high‑risk individuals.
- Minimise skin trauma: Choose professional, sterile techniques for piercings, tattoos, or elective surgeries.
- Pressure garments after surgery: Follow surgeon’s instructions for wearing compression for 6–12 months.
- Genetic counseling: Families with a strong history may benefit from counseling before elective procedures.
Complications
If left untreated or inadequately managed, keloids can lead to several problems:
- Persistent pain or pruritus affecting sleep and daily concentration.
- Functional limitation: Over‑large chest keloids can restrict breathing; across joints may impede movement.
- Infection: Ulceration or secondary infection can occur if the scar breaks.
- Psychosocial impact: Stigmatization, social withdrawal, and reduced quality of life.
- Secondary malignancy (rare): Chronic inflammation theoretically raises risk of skin cancers, though data are limited.
When to Seek Emergency Care
- Rapid swelling, redness, or warmth around the scar accompanied by fever – possible infection.
- Sudden, severe pain that does not improve with over‑the‑counter analgesics.
- Bleeding or drainage of pus from the scar.
- Signs of an allergic reaction after a recent injection (hives, difficulty breathing, swelling of the face or throat).
- Any indication that the scar is compromising breathing, swallowing, or vision.
References
- Mayo Clinic. Keloid scars: Diagnosis and treatment. 2023.
- NIH – National Center for Biotechnology Information. "Genetics of Keloid Formation." 2022.
- World Health Organization. Global skin disease burden report. 2021.
- Cleveland Clinic. Silicone gel sheets for scar management. 2024.
- American Academy of Dermatology. Intralesional steroids for keloids. 2023.
- Journal of Clinical Oncology. Post‑operative radiation reduces keloid recurrence. 2020.